EUVIMEDEUVIMED entdecken
Crossref

Lateral Transcervical In‐office Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction

Can Doruk iD, Michael J Pitman iD

The Laryngoscope · 2024

DOI: 10.1002/lary.30871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Can Doruk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Voice and Swallowing, Department of Otolaryngology-Head and Neck Surgery, Columbia University Irving Medical Center, New York, New York, U…. Hauptthemen laut MEDLINE: Botulinum Toxins, Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Operating room (OR) injection of botulinum toxin (BTX) injection is effective in the management of retrograde cricopharyngeal dysfunction (RCPD). This study aims to analyze the efficacy and safety of in‐office (IO) 30 Unit BTX injection into the cricopharyngeus via lateral transcervical approach.

Methods

A retrospective chart review of patients who underwent BTX injection either in the OR or IO for RCPD was performed. Postoperative success, defined by patient‐reported complete or near complete resolution of symptoms, side effects, and complication rates of each group was determined and compared. To determine the learning curve of IO injections, success rates of the injections performed in the early and late 6 months were compared. Chi‐square test was used for determining the statistical significance.

Results

Overall, 78 injections (37 IO and 41 OR) for RCPD were performed by the senior author. The success rate of OR injections (90.2%) is significantly higher than IO injections (64.9%) at the first‐month follow‐up ( p = 0.022). No significant difference was found in the side effect rates. Success and side effect rates were also similar in early and late injections ( p > 0.05).

Conclusions

IO lateral transcervical BTX injection for RCPD is a safe method that does not require general or topical anesthesia. While the side effects are similar and IO injections have many advantages, the success rates are lower than OR injections. Level of Evidence 3 Laryngoscope , 134:283–286, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum ToxinsBotulinum Toxins, Type ANeuromuscular AgentsHumansRetrospective StudiesInjectionsEsophageal Sphincter, UpperOperating RoomsTreatment Outcome

Stichwörter der Autor:innen

botulinum toxin injectionin-office procedureslaryngologyretrograde cricopharyngeal dysfunction

Substanzen

Botulinum ToxinsBotulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Center for Voice and Swallowing, Department of Otolaryngology-Head and Neck Surgery, Columbia University Irving Medical Center, New York, New York, U.S.A.

ORCID-Profile: Can Doruk, Michael J Pitman

Zitieren

APA

Doruk, C., & Pitman, M. J. (2024). Lateral Transcervical In‐office Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction. The Laryngoscope. https://doi.org/10.1002/lary.30871

Vancouver

Doruk C, Pitman MJ. Lateral Transcervical In‐office Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction. The Laryngoscope. 2024. doi:10.1002/lary.30871

BibTeX
@article{Doruk2024,
  author = {Doruk, Can and Pitman, Michael J},
  title = {Lateral Transcervical In‐office Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.30871}
}
Kostenlos starten →